{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:15:48Z","timestamp":1770977748413,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science and Technology Major Projects","award":["2012ZX09J1211003C"],"award-info":[{"award-number":["2012ZX09J1211003C"]}]},{"DOI":"10.13039\/501100014857","name":"NSFC-Guangdong Joint Fund","doi-asserted-by":"crossref","award":["U1032006"],"award-info":[{"award-number":["U1032006"]}],"id":[{"id":"10.13039\/501100014857","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejphar.2013.09.055","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T11:47:41Z","timestamp":1381146461000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Chlorbipram: A novel PDE4 inhibitor with improved safety as a potential antidepressant and cognitive enhancer"],"prefix":"10.1016","volume":"721","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3085-1191","authenticated-orcid":false,"given":"Ming-Zi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Zhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6969-3034","authenticated-orcid":false,"given":"Bing-Tian","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Fang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7872-6800","authenticated-orcid":false,"given":"Yu-Pin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.09.055_bib1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.braindev.2012.02.008","article-title":"Antiamnesic activity of Syzygium cumini against scopolamine induced spatial memory impairments in rats","volume":"34","author":"Alikatte","year":"2012","journal-title":"Brain and Development"},{"key":"10.1016\/j.ejphar.2013.09.055_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1192\/bjp.178.3.200","article-title":"Cognitive deficits in depression: possible implications for functional neuropathology","volume":"178","author":"Austin","year":"2001","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.ejphar.2013.09.055_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-0327(84)90031-4","article-title":"Weight gain. A side-effect of tricyclic antidepressants","volume":"7","author":"Berken","year":"1984","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.ejphar.2013.09.055_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neuropharm.2008.11.001","article-title":"Involvement of hippocampal CA3 KATP channels in contextual memory","volume":"56","author":"Betourne","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib5","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/j.1476-5381.2011.01524.x","article-title":"GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses","volume":"164","author":"Bruno","year":"2011","journal-title":"British Pharmacological Society"},{"key":"10.1016\/j.ejphar.2013.09.055_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-010-1943-3","article-title":"Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25-35 or Abeta1-40 peptide in rats","volume":"212","author":"Cheng","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2013.09.055_bib8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s12272-012-0719-1","article-title":"Attenuation of scopolamine-induced cognitive dysfunction by obovatol","volume":"35","author":"Choi","year":"2012","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.ejphar.2013.09.055_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.ejphar.2013.09.055_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-0173(01)00067-4","article-title":"Applications of the Morris water maze in the study of learning and memory","volume":"36","author":"D'Hooge","year":"2001","journal-title":"Brain Research Reviews"},{"key":"10.1016\/j.ejphar.2013.09.055_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0893-133X(99)00084-6","article-title":"Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus","volume":"22","author":"Fujimaki","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuropharm.2012.08.001","article-title":"Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target","volume":"64","author":"Goeldner","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2004.07.084","article-title":"Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats","volume":"498","author":"Itoh","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.lfs.2004.06.028","article-title":"The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats","volume":"76","author":"Janas","year":"2005","journal-title":"Life Sciences"},{"key":"10.1016\/j.ejphar.2013.09.055_bib15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.ejphar.2013.09.055_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11011-011-9235-0","article-title":"Prevention of cerebral ischemia-induced memory deficits by inhibition of phosphodiesterase-4 in rats","volume":"26","author":"Li","year":"2011","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.ejphar.2013.09.055_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1523\/JNEUROSCI.5236-10.2011","article-title":"Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling","volume":"31","author":"Li","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.ejphar.2013.09.055_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10401230209147454","article-title":"Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine","volume":"14","author":"Masand","year":"2002","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1016\/j.ejphar.2013.09.055_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchemneu.2010.03.004","article-title":"The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D","volume":"40","author":"Mori","year":"2010","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"10.1016\/j.ejphar.2013.09.055_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.ejphar.2013.09.055_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ajmg.b.30852","article-title":"Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population","volume":"150B","author":"Numata","year":"2009","journal-title":"American Journal of Medical Genetics Part B Neuropsychiatric Genetics"},{"key":"10.1016\/j.ejphar.2013.09.055_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tips.2004.01.003","article-title":"Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)","volume":"25","author":"O\u2019Donnell","year":"2004","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.ejphar.2013.09.055_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2013.09.055_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.neuropharm.2011.05.003","article-title":"MLC901, a traditional Chinese medicine protects the brain against global ischemia","volume":"61","author":"Quintard","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuropharm.2011.03.020","article-title":"Enhanced long-term depression and impaired reversal learning in phosphodiesterase 4B-knockout (PDE4B\u2212\/\u2212) mice","volume":"61","author":"Rutten","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib26","first-page":"132","article-title":"Effect of rolipram, a phosphodiesterase enzyme type-4 inhibitor, on gamma-amino butyric acid content of the frontal cortex in mice exposed to chronic mild stress","volume":"3","author":"Shalaby","year":"2012","journal-title":"Journal of Pharmacology and Pharmacotherapeutics"},{"key":"10.1016\/j.ejphar.2013.09.055_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2011.02.026","article-title":"5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: a pharmacodynamic and pharmacokinetic assessment","volume":"61","author":"Shen","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-007-1014-6","article-title":"Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme","volume":"197","author":"Siuciak","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.1976.01770020055009","article-title":"Memory functions in depression: improvement with antidepressant medication","volume":"33","author":"Sternberg De","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.ejphar.2013.09.055_bib30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1017\/S1461145711000836","article-title":"The phosphodiesterase-4 inhibitor rolipram reverses A\u03b2-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats","volume":"15","author":"Wang","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.56.1.170","article-title":"Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils","volume":"56","author":"Wang","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-2007-1017435","article-title":"Results of a phase II study of the antidepressant effect of rolipram","volume":"17","author":"Zeller","year":"1984","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2013.09.055_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002130000414","article-title":"Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats","volume":"150","author":"Zhang","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib35","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.2174\/138161209788168092","article-title":"Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs","volume":"15","author":"Zhang","year":"2009","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.ejphar.2013.09.055_bib36","first-page":"587","article-title":"Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme","volume":"27","author":"Zhang","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib37","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.npp.1300440","article-title":"Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus","volume":"29","author":"Zhang","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2013.09.055_bib38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pbb.2009.11.003","article-title":"Antidepressant effect of the extracts from Fructus Akebiae","volume":"94","author":"Zhou","year":"2010","journal-title":"Pharmacology Biochemistry and Behavior"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991300719X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991300719X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T10:12:59Z","timestamp":1588759979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991300719X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":37,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S001429991300719X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.055","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlorbipram: A novel PDE4 inhibitor with improved safety as a potential antidepressant and cognitive enhancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}